In kidney injuries, miR-500a-3p is thought to mitigate the toxicity and ischemic damage caused by necroptosis and inflammatory responses by targeting the MLKL and RIPK3 proteins according to experiments in HK2 cells [39]. This evidence concerns the gene RIPK3 and urogenital neoplasm.